SRI International

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross domestic product. McKinsey & Co. follows suit, noting AI could generate 30% efficiency gains and cost savings in the pharmaceutical sector and trigger financial gains of up to $110 billion annually.

As artificial intelligence continues to evolve at an unprecedented pace, a new organization has emerged to address one of the most profound and complex questions of our time: Can machines become sentient?

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

DUBAI, AE / ACCESS Newswire / March 14, 2025 / As financial markets become increasingly unpredictable, investors are seeking more reliable, data-driven solutions to manage risk and optimize decision-making.

Suki is establishing itself as a darling of some of the largest health care companies in the country. On March 3, Rush—the Chicago-based academic medical center—announced that it will deploy Suki's technology across its entire enterprise,

Intuitive Surgical is investing heavily in AI, AR, leading to future profitability. Learn why ISRG stock may present a buying opportunity.

Safe Superintelligence has become one of the most valuable companies in tech thanks to the reputation of former OpenAI researcher Ilya Sutskever.